Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · AHCL

AHCL

HealthcarePharmaceuticals & Biotechnology₹1352 cr market cap
₹25.00 ▼ -1.77% today As of 19 Nov 2026
52-week low ₹10.8252-week high ₹36.39

-30.1% from the 52-week high · +135.2% above the low

Anlon Healthcare Ltd manufactures pharmaceutical formulations, nutraceuticals, and health supplements. The company serves domestic and international markets with tablets, capsules, and wellness products. Its operations include research, production, quality assurance, and regulatory compliance. By delivering safe and effective health solutions, it contributes to overall well-being.

The short version. Return on equity was 12.4% in Mar 2026. Promoter holding was 52.68% in Sep 2026, up 0.00 points over 6 quarters.

1 · The price

How has the stock traded?

AHCL trades 30.1% below its 52-week high and 135.2% above its 52-week low.

Change over period: —

1M-5.6%
3M+75.2%
6M+91.2%
1Y+61.5%

2 · The business

Is it growing?

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026
Revenue1068851
Net profit13810
Net margin %12.79.520.6
EPS (₹)0.250.160.2

Annual

FY2026
Revenue172
Net profit29
Net margin %16.6
EPS (₹)0.54

3 · The quality

How well does it turn capital into profit?

Return on equity was 12.4% in Mar 2026; debt to equity is 0.19.

Profitability · 1 years

Returns and margins

Mar 2026
Return on equity %12.4
Return on capital %17.4
EBITDA margin %27.7
Net margin %16.6

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.19
Interest cover12.4x
Current ratio2.87
P/E ratio32.4

4 · The owners

Who holds it, and are they adding?

Promoter holding52.68%

Unchanged over 6 quarters.

Foreign institutions1.0%

Down 13.42 pts over 6 quarters.

Domestic institutions0.3%

Down 4.05 pts over 6 quarters.

Mutual fund schemes2

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter52.6852.6852.6852.6852.6852.680.0
FII14.4200.230.321.671.0-13.42
DII4.352.834.494.61.220.3-4.05
Public28.5544.4942.642.444.4346.02+17.47

Mutual fund holdings · Oct 2026

2 schemes hold this stock

2 the month before.

  • Motilal Oswal BSE Healthcare ETF0.04% of NAV
  • Bandhan BSE Healthcare Index Fund0.04% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for AHCL are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about AHCL

What is the AHCL share price?

AHCL (AHCL) last closed at ₹25.00, down 1.77% on the day. Its 52-week range is ₹10.82 to ₹36.39.

What is the market cap of AHCL?

AHCL has a market capitalisation of about ₹1,352 crore. Its price-to-earnings ratio is 32.4.

How are AHCL's latest results?

Return on equity was 12.4% in Mar 2026. Promoter holding was 52.68% in Sep 2026, up 0.00 points over 6 quarters.

Who owns AHCL?

As of Sep 2026, shareholding was: Promoter 52.68%, FII 1.0%, DII 0.3%, Public 46.02%.

How many mutual funds hold AHCL?

2 mutual fund schemes held AHCL in October 2026. That compares with 2 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 24 Apr 2026 · Bonus issue 1:1
  • 24 Apr 2026 · Stock Split From Rs.10/- to Rs.2/-

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.